Results 141 to 150 of about 4,234 (154)

Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK

Nature Medicine, 2021
Koen B Pouwels, Philippa Clare Matthews, Nicole Stoesser   +2 more
exaly  

Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant

Nature Medicine, 2022
Yu Gao, Curtis Cai, Alba Grifoni
exaly  

An overview of precision oncology basket and umbrella trials for clinicians

Ca-A Cancer Journal for Clinicians, 2020
Kristian Thorlund, Edward J Mills
exaly  

mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant

Nature Medicine, 2022
Henning Gruell, Kanika Vanshylla, Pinkus Tober-Lau   +2 more
exaly  

SARS-CoV-2 Omicron variant: recent progress and future perspectives

Signal Transduction and Targeted Therapy, 2022
Lei Zhang, Long Zhang, Fangfang Zhou
exaly  

Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis

Nature Medicine, 2021
Laurence Chu, David C Montefiori, Rolando Pajon   +2 more
exaly  

BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar

Nature Medicine, 2021
Patrick Tang, Mohammad Rubayet Hasan, Hiam Chemaitelly   +2 more
exaly  

Spread of a SARS-CoV-2 variant through Europe in the summer of 2020

Nature, 2021
Emma B Hodcroft, Moira Zuber, Sarah Nadeau   +2 more
exaly  

Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination

Nature Medicine, 2022
Chris Ka Pun Mok, Susanna S Ng, Eric Ho-Yin Lau   +2 more
exaly  

Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in Southern California

Nature Medicine, 2022
Sara Y Tartof
exaly